BDSX
BDSX
NASDAQ · Health Care

Biodesix Inc

$15.32
-0.15 (-0.97%)
As of May 16, 2:15 AM ET ·
Financial Highlights (FY 2026)
Revenue
114.14M
Net Income
-45,483,431
Gross Margin
81.1%
Profit Margin
-39.9%
Rev Growth
+32.3%
D/E Ratio
1.75
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 81.1% 81.1% 33.3% 33.3%
Operating Margin -31.5% -28.3% 8.0% 6.7%
Profit Margin -39.9% -37.9% 8.0% 7.4%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 114.14M 86.27M 49.37M 47.38M
Gross Profit 92.58M 69.97M 16.44M 15.77M
Operating Income -35,955,333 -24,457,561 3.95M 3.19M
Net Income -45,483,431 -30,938,770 3.95M 3.51M
Gross Margin 81.1% 81.1% 33.3% 33.3%
Operating Margin -31.5% -28.3% 8.0% 6.7%
Profit Margin -39.9% -37.9% 8.0% 7.4%
Rev Growth +32.3% +32.3% +11.0% +13.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 47.42M 47.42M 13.54M 13.68M
Total Equity 27.18M 27.18M 42.24M 42.97M
D/E Ratio 1.75 1.75 0.32 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -28,843,246 -20,709,760 4.35M 3.95M
Free Cash Flow 1.71M 2.32M